These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6234192)

  • 1. Heparan sulphate alterations in tumour cells.
    Winterbourne DJ; Khan Z
    Biochem Soc Trans; 1984 Jun; 12(3):540-1. PubMed ID: 6234192
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphation and fibronectin-binding properties of heparan sulphate glycosaminoglycans from transformed cultured human keratinocytes.
    Brown KW
    Br J Cancer; 1987 Mar; 55(3):295-7. PubMed ID: 2436645
    [No Abstract]   [Full Text] [Related]  

  • 3. A transformation-dependent difference in the heparan sulfate associated with the cell surface.
    Underhill CB; Keller JM
    Biochem Biophys Res Commun; 1975 Mar; 63(2):448-54. PubMed ID: 164863
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of sulfated mucopolysaccharides in cell recognition and neoplastic transformation.
    Dietrich CP; Sampaio LO; Montes de Oca H; Nader HB
    An Acad Bras Cienc; 1980 Mar; 52(1):179-86. PubMed ID: 6448018
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-polymeric glycosaminoglycans in transformed cells. Transformation-dependent changes in the co-polymeric structure of heparan sulphate.
    Fransson LA; Havsmark B; Chiarugi VP
    Biochem J; 1982 Jan; 201(1):233-40. PubMed ID: 6282259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
    Hennes R; Frantzen F; Keller R; Schirrmacher V; Schwartz-Albiez R
    Br J Cancer; 1988 Aug; 58(2):186-8. PubMed ID: 2971387
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in heparan sulfate pattern but not in oncogene expression correlate with tumor growth in spontaneous transformation of cells.
    Smith CA; Winterbourne DJ; McFarland VW; Mora PT
    Oncogene Res; 1987; 1(4):325-41. PubMed ID: 2966923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-polymeric glycosaminoglycans in transformed cells. Transformation-dependent changes in the self-associating properties of cell-surface heparan sulfate.
    Fransson LA; Sjöberg I; Chiarugi VP
    J Biol Chem; 1981 Dec; 256(24):13044-7. PubMed ID: 6273416
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycosaminoglycans and neoplastic transformation.
    Chiarugi VP
    Anticancer Res; 1982; 2(5):275-81. PubMed ID: 6819811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding of lactosaminoglycans and heparan sulphate to fibronectin synthesized by a human teratocarcinoma cell line.
    Cossu G; Andrews PW; Warren L
    Biochem Biophys Res Commun; 1983 Mar; 111(3):952-7. PubMed ID: 6220715
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of heparan sulphate and heparin to control and virus-transformed cells.
    Winterbourne DJ
    Biosci Rep; 1982 Dec; 2(12):1009-15. PubMed ID: 6299421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and metabolism of rat liver heparan sulphate.
    Oldberg A; Höök M; Obrink B; Pertoft H; Rubin K
    Biochem J; 1977 Apr; 164(1):75-81. PubMed ID: 141928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the distribution of O-sulphate groups of cell-surface and secreted heparan sulphate produced by human neuroblastoma cells in culture.
    Hampson IN; Kumar S; Gallagher JT
    Biochim Biophys Acta; 1983 Sep; 763(2):183-90. PubMed ID: 6225467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulphate proteoglycans.
    Gallagher JT; Turnbull JE; Lyon M
    Biochem Soc Trans; 1990 Apr; 18(2):207-9. PubMed ID: 2143154
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence of a small hydrophobic domain in the core protein of the heparan sulfate proteoglycan from human colon carcinoma cells.
    Iozzo RV; Ketterer CL; Slaymaker DJ
    FEBS Lett; 1986 Oct; 206(2):304-8. PubMed ID: 2944764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of transformation, cell density, and growth control to the cellular distribution of newly synthesized glycosaminoglycan.
    Cohn RH; Cassiman JJ; Bernfield MR
    J Cell Biol; 1976 Oct; 71(1):280-94. PubMed ID: 977651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are heparan sulphate (HS) sulphotransferases implicated in the pathogenesis of Alzheimer's disease?
    Zebrower M; Kieras FJ
    Glycobiology; 1993 Feb; 3(1):3-5. PubMed ID: 8448383
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of heparin and heparan sulphate to rat liver cells.
    Kjellén L; Oldberg A; Rubin K; Höök M
    Biochem Biophys Res Commun; 1977 Jan; 74(1):126-33. PubMed ID: 138421
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration of a platelet enzyme, degrading heparan sulphate.
    Wasteson A; Höök M; Westermark B
    FEBS Lett; 1976 Apr; 64(1):218-21. PubMed ID: 131710
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin releases heparan sulfate from the cell surface.
    Kraemer PM
    Biochem Biophys Res Commun; 1977 Oct; 78(4):1334-40. PubMed ID: 144504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.